Today: 12 March 2026
Browse Category

Stock Market 7 December 2025

VGT Stock Today: Vanguard Information Technology ETF Near Record Highs as Big Tech Dominance Sparks Debate (December 7, 2025)

VGT Stock Today: Vanguard Information Technology ETF Near Record Highs as Big Tech Dominance Sparks Debate (December 7, 2025)

The Vanguard Information Technology ETF (VGT) closed at $767.97 on December 5, near its all-time high, after gaining 19% over the past year. Nvidia, Apple, and Microsoft now make up about 45% of VGT’s value. The fund manages roughly $113 billion in assets and charges a 0.09% expense ratio. Recent commentary highlights both concentration risks and VGT’s strong performance versus other tech ETFs.
SQQQ Stock Outlook Today (December 7, 2025): Is the 3x Inverse Nasdaq ETF Running Out of Steam?

SQQQ Stock Outlook Today (December 7, 2025): Is the 3x Inverse Nasdaq ETF Running Out of Steam?

ProShares UltraPro Short QQQ (SQQQ) closed at $66.49 on December 5, down 1.14%, capping an eight-loss streak in ten sessions and a 17.8% drop over two weeks. Assets under management remain near $2.5 billion, with daily volume above 30 million shares. SQQQ’s one-year total return stands near –56%, with technical signals flashing “sell” and volatility exceeding 50%.
7 December 2025
TSLL Stock Outlook: Is Direxion’s 2X Tesla ETF Still Worth the Risk After December’s Rally?

TSLL Stock Outlook: Is Direxion’s 2X Tesla ETF Still Worth the Risk After December’s Rally?

Direxion Daily TSLA Bull 2X Shares ETF (TSLL) surged about 30% in two weeks, trading near $20.60 as of December 7, 2025, with gains in 8 of the last 10 sessions. Despite the rally, TSLL remains down roughly 30% year-to-date and far below its 52-week high of $40.57. Assets under management stand near $7 billion, with average daily volume around 134 million shares.
7 December 2025
Lowe’s (LOW) Stock Outlook for 2026: Can a Dividend King Win After the FBM Mega‑Deal and Forecast Cut?

Lowe’s (LOW) Stock Outlook for 2026: Can a Dividend King Win After the FBM Mega‑Deal and Forecast Cut?

Lowe’s shares closed at $248.47 on December 5, 2025, near the middle of their 52-week range, with a market cap of $139.4 billion. The stock is down double digits over the past year despite beating Q2 earnings estimates and closing an $8.8 billion acquisition. 2025 guidance remains cautious, citing weak demand for big-ticket home projects. The S&P 500 is up over 13% in the same period.
7 December 2025
RCAT Stock Forecast for 2025–2026: Can Red Cat Holdings Turn the Drone Supercycle Into Lasting Gains?

RCAT Stock Forecast for 2025–2026: Can Red Cat Holdings Turn the Drone Supercycle Into Lasting Gains?

Red Cat Holdings closed at $8.02 on December 5, 2025, valuing the company at about $957 million, roughly 52% below its October high. Shares jumped nearly 9% after Red Cat named a new CFO and promoted its CFO to COO on December 2. Trading volume was about half the daily average. The stock remains volatile, sitting 75% above its 52-week low but still down 5% year-over-year.
REIT Stock Prices on December 7, 2025: Are Rate Cuts Setting Up a 2026 Rally?

REIT Stock Prices on December 7, 2025: Are Rate Cuts Setting Up a 2026 Rally?

The FTSE Nareit All REITs Index slipped 0.11% on December 5, while the Mortgage REITs Index rose 0.38%. The Vanguard Real Estate ETF closed at $89.88, down 6% over the past year. Listed REITs show higher or equal occupancy rates than private funds in most sectors, but trade at cheaper valuations. The valuation gap between REITs and the S&P 500 has widened to levels last seen during major market shocks.
Walgreens Boots Alliance (WBA) Stock in December 2025: Buyout Price, Delisting, and What’s Left for Investors

Walgreens Boots Alliance (WBA) Stock in December 2025: Buyout Price, Delisting, and What’s Left for Investors

Walgreens Boots Alliance was taken private by Sycamore Partners on August 28, 2025, and its WBA shares were delisted from Nasdaq. Shareholders received $11.45 per share in cash plus a right tied to VillageMD asset sales. The last trading price was about $11.98. Recent headlines focus on a December 3 data breach and real estate moves, but WBA stock no longer trades.
VOO Stock Today: Vanguard S&P 500 ETF Near Record Highs as Inflows Smash All‑Time Records (December 7, 2025)

VOO Stock Today: Vanguard S&P 500 ETF Near Record Highs as Inflows Smash All‑Time Records (December 7, 2025)

Vanguard’s S&P 500 ETF (VOO) closed at $630.48 on December 5, 2025, near its 52-week high, and became the world’s largest ETF with assets topping $800 billion. November saw record inflows of nearly $21 billion, pushing year-to-date inflows to about $120–125 billion. The fund’s 1-year return is around 16%, with a dividend yield near 1.1% and a P/E ratio of 29.
7 December 2025
ANET Stock Forecast: Why Analysts Still See Big Upside for Arista Networks After Its Latest Pullback

ANET Stock Forecast: Why Analysts Still See Big Upside for Arista Networks After Its Latest Pullback

Arista Networks shares closed near $129, down about 22% from their 52-week high but more than double their 52-week low. Q3 2025 revenue rose 27.5% year-over-year to $2.31 billion, with earnings beating estimates. Management projects Q4 revenue of $2.3–2.4 billion. Analysts maintain a bullish outlook, with a median price target near $167.50 and no “Sell” ratings.
ServiceNow (NOW) Stock on December 7, 2025: Stock Split, Veza Deal and 2025 Outlook for the AI Workflow Leader

ServiceNow (NOW) Stock on December 7, 2025: Stock Split, Veza Deal and 2025 Outlook for the AI Workflow Leader

ServiceNow shares closed at $854 on December 5, 2025, ahead of a 5-for-1 stock split set to take effect December 18. The company’s stock is down about 20% year-to-date but remains up over 100% in three years. Shareholders approved the split, which will lower the share price to around $170 post-split. ServiceNow also announced the acquisition of Veza to expand in identity security.
INO Stock: Inovio’s FDA BLA Milestone, New Equity Offerings and 2026 Catalyst – Latest News and Forecasts (December 7, 2025)

INO Stock: Inovio’s FDA BLA Milestone, New Equity Offerings and 2026 Catalyst – Latest News and Forecasts (December 7, 2025)

Inovio Pharmaceuticals closed at $2.07 on December 5, up 2.5% for the day and nearly 20% over the past 10 sessions, with volume near 1 million shares. The stock recently crossed its 200-day moving average, while short interest remains high at 34% of daily volume. Wall Street’s average 12-month price target is $9, despite continued losses and minimal revenue.
Southwest Airlines Stock (LUV) Near 52‑Week High After Fine Waiver and Profit Cut: Outlook, Forecasts and Risks as of December 7, 2025

Southwest Airlines Stock (LUV) Near 52‑Week High After Fine Waiver and Profit Cut: Outlook, Forecasts and Risks as of December 7, 2025

Southwest Airlines shares closed near a 52-week high at $37.87 on December 5, 2025, up 20% in a month despite the company cutting its 2025 profit outlook after a 43-day U.S. government shutdown and higher fuel costs. U.S. regulators also waived an $11 million fine related to the airline’s 2022 holiday meltdown. Market capitalization stands near $19.6 billion.
7 December 2025
CleanSpark (CLSK) Stock on December 7, 2025: Earnings Surge, $1.15B Notes Deal and AI Pivot – What Investors Need to Know

CleanSpark (CLSK) Stock on December 7, 2025: Earnings Surge, $1.15B Notes Deal and AI Pivot – What Investors Need to Know

CleanSpark shares fell 8.7% to $13.72 on December 5, 2025, after fiscal 2025 results missed Wall Street estimates despite revenue more than doubling to $766.3 million and a swing to $364.5 million net profit. Trading volume topped 32.7 million shares. The company holds over 13,000 BTC and recently announced a $1.15 billion convertible notes deal tied to a major buyback.
KULR Stock in 2025: Q3 Earnings, Bitcoin Treasury Strategy, and Wall Street Forecasts Explained

KULR Stock in 2025: Q3 Earnings, Bitcoin Treasury Strategy, and Wall Street Forecasts Explained

KULR Technology Group shares traded near $3.93 in early December 2025, with a market cap around $180 million and daily volume of 1.36 million. The stock surged 1,819% in 2024 after a $21 million Bitcoin purchase, then fell over 50% in 2025. KULR supplies battery safety and thermal management tech for aerospace and defense, including NASA-certified products.
BP Stock Today: Bank of America Downgrade, $750m Buyback and Hydrogen U‑Turn — December 7, 2025 Update

BP Stock Today: Bank of America Downgrade, $750m Buyback and Hydrogen U‑Turn — December 7, 2025 Update

BP’s New York shares closed at $35.83 on December 5, down 3.8% for the day but up year-on-year, while London shares traded at 452.85p, up 18% over 12 months. Bank of America downgraded BP to “underperform” on December 6, citing weaker oil price forecasts and concerns over asset sales. BP continues a $750 million buyback and maintains a 5.4% dividend yield.
7 December 2025
Nike (NKE) Stock on December 7, 2025: Leadership Shake-Up, China Slowdown and Dividend Hike Shape the Outlook

Nike (NKE) Stock on December 7, 2025: Leadership Shake-Up, China Slowdown and Dividend Hike Shape the Outlook

Nike shares traded near $65.86 Friday, with the stock down about 11% over the past three months. The company announced a major leadership shake-up December 2 to accelerate its “Win Now” turnaround plan. The UK’s ad regulator banned Nike sustainability ads this week for misleading environmental claims. Nike’s market cap stands at roughly $97 billion.
7 December 2025
Merck (MRK) Stock Outlook on December 7, 2025: Price Action, Keytruda Setback, Debt Deal and 2026 Analyst Forecasts

Merck (MRK) Stock Outlook on December 7, 2025: Price Action, Keytruda Setback, Debt Deal and 2026 Analyst Forecasts

Merck closed an $8 billion senior notes offering, likely to help fund its $9.2 billion Cidara Therapeutics acquisition. The company also reported new regulatory wins and raised its dividend, but faced a patent setback for subcutaneous Keytruda in Germany. Merck shares ended December 5 at $99.72, down 1.2%, and remain near the top of their 52-week range. Trading volume was above average.

Stock Market Today

  • Zumiez Q4 2025 Revenue Beats Estimates Despite Stock Drop
    March 12, 2026, 5:47 PM EDT. Zumiez (NASDAQ:ZUMZ) reported Q4 CY2025 revenue of $291.3 million, up 4.4% year-on-year and 0.8% above analyst estimates. GAAP EPS rose 8.9% above expectations to $1.16 per share. Adjusted EBITDA reached $37.43 million, a 25.6% beat, driven by strong sales in North America and improved product margins in Europe. Revenue guidance for Q1 CY2026 stands at $191 million, 2.5% higher than forecasts, though EPS guidance of -$0.82 missed estimates by 9.3%. Operating margin expanded to 8.6% from 7.2% the previous year. Zumiez ended the quarter with 716 stores, down from 730 a year earlier, and same-store sales increased 2.2%. CEO Rick Brooks highlighted progress in merchandise and expense management amid ongoing efforts to drive growth and shareholder value.
Go toTop